Insider · CIK 0001571997
Gullans Steven R. Ph.D.
Reports to the SEC for 4 companies · BOSTON, MA
Transactions
24
Companies
4
Filings
15
CIK
0001571997
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-01-02 | ISPCiSpecimen Inc. · OptionA Award | +$5,300 |
| 2023-01-03 | ISPCiSpecimen Inc. · OptionA Award | +$14.1K |
| 2023-01-01 | ISPCiSpecimen Inc.A Award | — |
| 2022-10-01 | ISPCiSpecimen Inc.A Award | — |
| 2021-07-30 | ISPCiSpecimen Inc. · Non-Qualified Stock OptionsA Award | — |
| 2021-07-30 | ISPCiSpecimen Inc.A Award | — |
| 2020-01-13 | MTVAMetaVia Inc. · Non-qualified stock option (right to buy)A Award | — |
| 2019-07-24 | MTVAMetaVia Inc.A Award | — |
| 2018-05-22 | MTVAMetaVia Inc. · Employee Stock Option (right to buy)A Award | — |
| 2018-05-22 | MTVAMetaVia Inc. · Employee Stock Option (right to buy)A Award | — |
| 2018-05-01 | MTVAMetaVia Inc. · Employee Stock Option (right to buy)A Award | — |
| 2018-02-08 | MTVAMetaVia Inc.P Purchase | +$500K |
| 2018-01-29 | MTVAMetaVia Inc. · Employee Stock Option (right to buy)A Award | — |
| 2017-05-30 | MTVAMetaVia Inc. · Employee Stock Option (right to buy)A Award | — |
| 2017-03-10 | MTVAMetaVia Inc. · Warrant to Purchase Common StockP Purchase | +$375K |
| 2017-03-10 | MTVAMetaVia Inc.P Purchase | +$500K |
| 2016-08-10 | MTVAMetaVia Inc.C Conversion | +$2.05M |
| 2016-08-10 | MTVAMetaVia Inc.P Purchase | +$5M |
| 2016-08-10 | MTVAMetaVia Inc. · 8% Convertible Subordinated Promissory NoteC Conversion | — |
| 2016-08-04 | MTVAMetaVia Inc. · Stock Option (right to buy)A Award | — |
| 2013-03-25 | TETRAPHASE PHARMACEUTICALS INCSeries C Convertible Participating Preferred StockC Conversion | — |
| 2013-03-25 | TETRAPHASE PHARMACEUTICALS INCNon-qualified stock option (right to buy)A Award | — |
| 2013-03-25 | TETRAPHASE PHARMACEUTICALS INCP Purchase | +$3.47M |
| 2013-03-25 | TETRAPHASE PHARMACEUTICALS INCC Conversion | — |
Recent filings
- 4Gullans Steven R. Ph.D.0001104659-24-063356SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001104659-23-061736SEC(opens sec.gov)
- 5Gullans Steven R. Ph.D.0001104659-23-018755SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001104659-23-003747SEC(opens sec.gov)
- 5Gullans Steven R. Ph.D.0001104659-22-022568SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001683168-20-000157SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001596771-19-000080SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001596771-18-000061SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001596771-18-000053SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001596771-18-000019SEC(opens sec.gov)
- 4Gullans Steven R. Ph.D.0001596771-18-000009SEC(opens sec.gov)
- 4Gemphire Therapeutics Inc.0001596771-17-000041SEC(opens sec.gov)
- 4Gemphire Therapeutics Inc.0001596771-17-000020SEC(opens sec.gov)
- 4Gemphire Therapeutics Inc.0001104659-16-139272SEC(opens sec.gov)
- 4Gemphire Therapeutics Inc.0001596771-16-000146SEC(opens sec.gov)
Companies
Address
800 BOYLSTON ST. SUITE 2825
BOSTON, MA, 02199